Form 4: Beyond Air CEO Steven Lisi Reprices Stock Options to $0.54

Beyond Air's CEO, Steven Lisi, had his stock options repriced to $0.54 per share on November 22, 2024, as part of a board-approved repricing initiative.

Summary

• On November 22, 2024, Beyond Air's Board of Directors approved a repricing of stock options held by CEO Steven A. Lisi.
• The exercise price of these options was reduced to $0.54 per share, which was the closing price of the company's common stock on that date.
• The repricing affected multiple tranches of options, totaling 3,150,000 shares.
• The original exercise prices of the options ranged from $1.53 to $6.87 per share.
• All other terms of the options, including vesting schedules, remain unchanged.

Sentiment

Score: 4

Explanation: The repricing of stock options is generally a negative signal, suggesting the company's stock price has not performed as expected. While it may incentivize the CEO, it also reduces potential profit for the company if the stock price increases.

Positives

• The repricing aligns the CEO's stock options with the current market value of the company's stock.
• The repricing may incentivize the CEO to improve company performance, as the options are now more likely to be in the money.
• The repricing was approved by the Board of Directors, indicating a level of corporate governance.

Negatives

• The repricing significantly reduces the potential profit for the company if the stock price increases, as the options are now exercisable at a much lower price.
• The repricing may be seen as a negative signal by some investors, as it suggests the previous option prices were not achievable.

Risks

• The repricing could be perceived negatively by shareholders if the stock price does not increase significantly.
• There is a risk that the repricing may not provide the intended incentive if the stock price remains low.
• The repricing could lead to dilution of existing shareholders if the options are exercised.

Management Comments

• The Board of Directors approved the option repricing, effective as of November 22, 2024.
• All other terms of the options remain unchanged.

Industry Context

Stock option repricing is a common practice, especially when a company's stock price has declined significantly. It is often used to retain and incentivize key executives.

Comparison to Industry Standards

• Repricing of stock options is not uncommon in the biotech industry, especially for companies with volatile stock prices.
• Companies like XOMA and Agenus have also repriced options in the past to align executive incentives with current market conditions.
• The specific terms of the repricing, such as the new exercise price and the number of options affected, are specific to Beyond Air and its circumstances.

Stakeholder Impact

• Shareholders may view the repricing negatively if the stock price does not increase.
• The CEO is likely to be positively impacted by the repricing, as the options are now more likely to be in the money.
• Employees holding stock options may also be impacted by the repricing.

Key Dates

Keywords

stock options, repricing, CEO, Steven Lisi, Beyond Air, equity incentive, corporate governance